Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

N-Acryloxysuccinimide

    • Product Name N-Acryloxysuccinimide
    • Alias NAS
    • Einecs 247-361-2
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    493537

    Chemical Name N-Acryloxysuccinimide
    Cas Number 27274-31-3
    Molecular Formula C7H7NO4
    Molecular Weight 169.14
    Appearance White to off-white solid
    Melting Point 75-77°C
    Purity Typically ≥98%
    Solubility Soluble in organic solvents (e.g., DMSO, DMF, chloroform)
    Storage Conditions Store at 2-8°C, protect from light and moisture
    Synonyms N-(2-Propenoyloxy)succinimide
    Inchi InChI=1S/C7H7NO4/c1-2-8-7(11)6(10)4-3-5-9-6/h2-3H,1,4-5H2
    Smiles C=CC(=O)ON1C(=O)CCC1=O

    As an accredited N-Acryloxysuccinimide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing N-Acryloxysuccinimide is packaged in a 5-gram amber glass bottle with a secure screw cap and clear hazard labeling.
    Shipping N-Acryloxysuccinimide should be shipped in tightly sealed containers under cool, dry conditions. It must be protected from light, moisture, and sources of ignition. The chemical should be packed according to regulations for hazardous materials, clearly labeled, and transported by qualified carriers, ensuring compliance with all relevant safety and shipping regulations.
    Storage N-Acryloxysuccinimide should be stored in a cool, dry, and well-ventilated area, away from heat sources, sunlight, and moisture. Keep in a tightly closed container, protected from exposure to air and incompatible substances such as strong oxidizers or acids. Store under an inert atmosphere like nitrogen if possible, and ensure proper labeling to prevent accidental misuse or contamination.
    Application of N-Acryloxysuccinimide

    Applications of N-Acryloxysuccinimide in Industrial Manufacturing

    N-Acryloxysuccinimide serves as a key activated ester for highly specific coupling reactions in advanced industrial production environments. Its unique reactivity supports downstream manufacturers in creating reliable covalent modifications in both bioconjugation and polymer functionalization settings, especially where process precision and reproducibility are mission-critical. The following sections detail the established industrial domains where our material is used, covering the compliance standards, integration mode, formulation ratios, and the corresponding end products.

    1. Antibody-Drug Conjugate (ADC) Manufacturing

    N-Acryloxysuccinimide provides an activated acrylate group enabling site-specific conjugation of cytotoxic agents to monoclonal antibodies. This precision linker chemistry supports the manufacture of targeted biopharmaceuticals under strict regulatory regimes, requiring consistent bond formation and batch QC traceability. The material enters directly during the linker-drug intermediate synthesis step, where control over conjugation efficiency and product purity determines clinical batch release.

    Industry compliance standards

    • ICH Q7 (Good Manufacturing Practice for Active Pharmaceutical Ingredients)
    • US FDA CFR Title 21, Sections 210, 211 (cGMP for Drug Products)
    • EU GMP Annex 2 (Manufacture of Biological Medicinal Substances)
    • USP General Chapter <797> (Pharmaceutical Compounding—Sterile Preparations)

    Typical usage ratio

    • 0.7–1.2 molar equivalents per available lysine or cysteine residue on the mAb, adjusted based on payload-to-antibody ratio targets (DAR), often determined by process optimization data and target conjugation density.

    Downstream process integration

    • Integrated during the linker-payload synthesis phase, dissolved in anhydrous organic solvent and reacted under controlled pH and temperature; excess is removed by ultrafiltration before antibody coupling.

    Final product types

    • Antibody-drug conjugates (ADC therapeutics)
    • Preclinical research-grade conjugates
    • Validated drug-linker intermediates for CDMO supply

    2. Activated Polymer Functionalization for Biomedical Devices

    Industrial users utilize N-Acryloxysuccinimide as an activated monomer for introducing succinimidyl ester groups onto polymer backbones by radical co-polymerization or post-polymerization modification. This enables further covalent immobilization of peptides and proteins, key to medical device coatings for implantables and diagnostic consumables. Device manufacturers demand tight batch reproducibility, material traceability, and compliance with rigorous endotoxin and leachables controls.

    Industry compliance standards

    • ISO 10993-1: Biological Evaluation of Medical Devices
    • USP Class VI Plastics (Biological Reactivity Tests)
    • 21 CFR 820 (FDA Quality System Regulation for Medical Devices)
    • ISO 13485:2016 (Medical device QMS requirements)

    Typical usage ratio

    • 0.2–5.0 wt% relative to the total polymer feed; fine-tuned by the specific activation density required for surface functionalization, generally determined by downstream protein coupling efficiency.

    Downstream process integration

    • Added directly to monomer solution before bulk or emulsion polymerization, or grafted onto pre-formed polymer substrates via tailored surface reactions; followed by post-process washing and sterilization.

    Final product types

    • Protein-functionalized implantable medical devices (e.g., vascular grafts, orthopedic components)
    • In vitro diagnostic plate and tube coatings
    • Drug-eluting stent polymers

    3. Protein and Peptide Immobilization for Chromatography Resin Manufacturing

    Specialty resin producers adopt N-Acryloxysuccinimide to introduce activated ester functionalities on chromatographic bead surfaces, supporting stable covalent immobilization of proteins, peptides, or affinity ligands via primary amines. Exacting control over loading uniformity and elimination of residual free esters drive resin performance and industry acceptance, especially in bioprocess purification and diagnostic reagent supply chains.

    Industry compliance standards

    • ISO 9001:2015 (Quality Management Systems – Requirements)
    • EMEA Guideline on the Requirements for Quality Documentation (Biotechnology-derived Pharmaceuticals)
    • US FDA CFR Title 21, Part 211 (cGMP for Finished Pharmaceuticals)
    • EDQM guidelines for pharmaceutical raw materials

    Typical usage ratio

    • 0.5–2.5 mmol/g based on bead surface area; loading is adjusted by the functional group accessibility and desired ligand density, as established by proprietary resin design protocols.

    Downstream process integration

    • Applied during surface activation after bead polymerization; beads are suspended in organic solvent containing the material, with reaction time, temperature, and pH closely controlled to maximize coupling efficiency before thorough rinsing and blocking of unreacted sites.

    Final product types

    • Affinity chromatography resins for biomanufacturing
    • Immunoprecipitation beads
    • Enzyme immobilization supports

    4. Site-Specific PEGylation of Therapeutic Peptides

    Chemical manufacturers producing PEGylated biologics use our activated ester as a coupling intermediate to bind polyethylene glycol (PEG) chains to N-termini or lysine residues on peptides and small proteins. This modification prolongs half-life and enhances pharmacokinetics of peptide drugs, with rigorous batch monitoring and chain-length verification required for regulatory submissions and lot-to-lot uniformity.

    Industry compliance standards

    • Ph. Eur. (European Pharmacopoeia) Monographs relevant to PEGs and peptide drugs
    • ICH Q6B (Specifications: Test Procedures and Acceptance Criteria for Biotechnological Products)
    • US FDA Guidance for Industry: Immunogenicity Assessment for Therapeutic Protein Products
    • GMP for API Production (FDA/EU)

    Typical usage ratio

    • 1.0–1.5 molar equivalents per reactive amine group; actual dose is titrated based on peptide sequence, structural constraints, and required degree of PEGylation, typically validated during process scale-up.

    Downstream process integration

    • Introduced after peptide synthesis and purification, dissolved in buffered aqueous-organic mixtures under controlled pH; excess reactant is removed by chromatographic separation or ultrafiltration.

    Final product types

    • PEGylated peptide APIs
    • Half-life extended biotherapeutics
    • Parenteral peptide drug preparations
    Free Quote

    Competitive N-Acryloxysuccinimide prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    N-Acryloxysuccinimide: Manufacturing Perspective and Industry Insights

    A Close Look at N-Acryloxysuccinimide

    N-Acryloxysuccinimide (CAS 923-61-5) remains a staple in our production line, known among chemists and material scientists for its efficiency in peptide synthesis and bioconjugation. Over the years, requests for this compound have steadily grown, especially from research institutions and pharmaceutical labs pursuing complex molecule modifications. Through experience on the manufacturing floor, we see demand surging every time a new method for targeted protein labeling or site-specific conjugation emerges in the literature. Our production team pays close attention to purity standards, usually offering material upward of 98%—a figure established after years of feedback from end users frustrated by inconsistent yields caused by impurities in lesser grade alternatives.

    Manufacturing and Quality Control Practices

    At the heart of quality lies repetition and feedback. Our standard for N-Acryloxysuccinimide has always favored a white to off-white crystalline powder, with melting points and HPLC results indicating batch consistency. We use custom glass reactors with chilling jackets for temperature-sensitive steps, which helps prevent byproduct formation. This matters a great deal, as any hydrolysis during process or storage reduces the activated ester’s shelf life and reactivity.

    Repeated audits and real-world application feedback allow us to spot minor, hidden issues in production. Moisture remains the prime enemy; exposure to air can lead to partial hydrolysis, lowering the reactivity toward amine groups. Workers at our facility have learned to keep materials under inert gas and pack product in vacuum-sealed bags within desiccated rooms. These minor logistics keep shelf stability above twelve months, a point closely monitored in every batch release. Controls like these don’t just protect our reputation—they allow researchers to proceed with confidence, since their results depend directly on our attention to detail at every step.

    Why Purity and Process Matter

    Years back, a large biotech client nearly scrapped several runs of antibody-drug conjugates due to low coupling efficiency. After a deep dive, it became clear that contaminants—not inherent flaws in their method—were the problem. Contaminated batches can introduce competing nucleophiles or acids, dramatically reducing targeted modification rates. The lesson applies to any product where functional group reactivity must remain tightly controlled. As a result, our own teams refined pre-purification steps and added inline monitoring. Strict HPLC and NMR profiling catch issues before shipment, saving downstream troubleshooting for our partners.

    We run two models of N-Acryloxysuccinimide: standard and high-purity, both available with certificates of analysis tracing every lot to raw feedstock. We’ve moved toward single-source raw material procurement for the acrylate base, which minimizes batch-to-batch variation. For some researchers, minor trace metals or even sub-percent organics can steer experiments toward irreproducible results. They tell us directly which contaminants matter most in their applications, and we in turn adjust processes in response. The goal is predictable, high-performing product, whether being used in custom nucleic acid labeling or solid-phase immobilization.

    Differences from Related Compounds

    We manufacture several activated esters, but N-Acryloxysuccinimide stands apart from related NHS esters (N-hydroxysuccinimide esters) in both reactivity and stability. While NHS-methacrylate and other acrylate esters often degrade faster or introduce side products during coupling, N-Acryloxysuccinimide’s structure gives it balance: the succinimide ring promotes rapid, clean amide bond formation with primary amines, while the acrylate group invites controlled polymerization. This dual role streamlines synthesis steps, especially in site-specific protein modifications or in preparing monomer units for advanced materials.

    Some chemical plants prefer methacrylate-activated esters for higher shelf stability, but these lose reactivity compared to the acryloxy variant. When scale-up is needed, the real-world tradeoff between shelf life and coupling rate tips the balance; clients pursuing maximum yield or reactivity always circle back to N-Acryloxysuccinimide. Over years supplying both, the data consistently confirms faster coupling with the acryloxy derivative, with minimal residual unreacted amine in finished products. We see fewer issues of incomplete modification or unwanted self-polymerization than with isomeric versions.

    Application Experience: Protein Labeling, Bioconjugation, Polymer Chemistry

    Our batches regularly ship to universities and startup labs working on innovative biosensors and medical diagnostics. Researchers designing new antibody-drug conjugates or fluorescence probes often favor N-Acryloxysuccinimide for amine-reactive site-specific modification, because rushed or incomplete coupling can waste entire series of high-value protein drugs. Hearing firsthand from teams that a single failed batch can mean days or weeks lost drives our own vigilance for product purity.

    We often hear from users that off-the-shelf alternatives produce less consistent results. They report odor or color changes in other suppliers’ lots, which often signals breakdown. Some experiments are sensitive enough to react to even sub-percent levels of hydrolyzed byproducts. In polymer chemistry, incorporation of N-Acryloxysuccinimide allows for anchoring polymers onto proteins or dendrimers at precisely mapped points—fine-tuning not just the material structure, but also downstream biological activity. Such site-specificity proves valuable in targeted drug delivery or in developing responsive hydrogels for tissue engineering.

    In synthesis work, researchers often rely on N-Acryloxysuccinimide to produce activated acrylate intermediates for co-polymerization. The acrylate’s unique reactivity also benefits applications where cross-link density needs tuning for mechanical properties (as in high-performance elastomers or medical devices). The compound’s dual functional groups give synthetic chemists flexibility, letting them introduce either amine modifications (on the succinimide end) or grow extended acrylic networks.

    Industry Challenges and Practical Solutions

    Keeping up with tightening purity requirements pushes improvements throughout our plant. Years ago, packaging involved polyethylene bags and paper cartons, which let trace moisture sneak in, degrading sensitive lots before reaching clients’ labs. With real-world feedback—and a few expensive lessons—our plant now uses foil-laminate vacuum pouches with humidity indicators in every shipment. These details reduce risk for our clients, who increasingly standardize quality control checks upon receipt.

    Transportation is a further pain point; we learned that summer shipments across equatorial ports caused unseen hydrolysis, traced only after repeat client complaints. Our logistics now include temperature and humidity monitoring in transit. We switched carriers and regularly monitor warehouse storage, keeping everything cool and dry.

    Regulations around activated esters are evolving, especially in the European Union and East Asia, focusing not just on bulk packaging but also worker safety and potential environmental release. As manufacturers, we keep up with these rules by continuously auditing both upstream and downstream supply chains, implementing mandatory training for our own operators, and collaborating with outside compliance experts. This ongoing diligence prevents disruptions from regulatory shifts, and lets customers focus on research, not paperwork.

    Research and Development: Meeting Users’ Requests

    R&D doesn’t stop at producing established grades of N-Acryloxysuccinimide. Feedback cycles with direct users continuously shape process innovation. Teams tell us about new labeling methods or coupling challenges and expect either purer or differently stabilized lots. We have invested in small-batch testing and real-time process analytics to accelerate troubleshooting. For special applications—like labeling particularly sensitive peptides—we manufacture ultra-dry, oxygen-free lots using gloveboxes and Argon backfill. The extra steps pay off by opening up new markets, especially in multi-gram or sub-gram scale orders for custom research projects.

    Analytical development also tracks new contaminants or process byproducts. Sometimes, a side product unknown two years ago suddenly matters to a customer scaling up new diagnostics. By running advanced LC/MS/MS alongside traditional HPLC, we keep track of even low-level impurities, far below what old specifications tracked. Our in-house analytical work often detects emerging contaminants ahead of formal customer requests.

    Environmental Responsibility and Safe Handling

    Manufacturing activated esters can be a challenge in terms of both waste minimization and safe worker handling. Over the past decade, regulators and customers alike have raised the bar for environmental responsibility. We reclaimed solvents through in-plant distillation units long before the practice became standard industry-wide. Tight waste controls keep both environmental risk and costs manageable.

    Employee safety training includes regular drills, not just annual meetings. Employees who face these compounds every day grow skilled at spotting early signs of instability or container breaches. Combined with real-time air monitoring and use of sealed reactors, these steps build both trust and expertise into every kilogram that leaves the plant.

    Customer Partnerships and Continuing Support

    Unlike pure commodity chemicals, activated esters like N-Acryloxysuccinimide require ongoing manufacturer involvement. Clients often wish to know background details for complex documentation—from supply chain audits to detailed impurity profiles. Our customer support team includes chemists and process engineers with first-hand production knowledge, who work directly with researchers to answer technical questions and even redesign process routes for special projects. Sometimes a request for extra-dry product comes with a direct phone call to the plant floor, and our team responds without delay.

    We also supply technical documentation for cGMP and non-GMP needs, letting pharmaceutical partners trace every step of a lot’s manufacturing journey. Having these records organized and accessible allows our clients to complete their own audits or regulatory filings quickly. The real-world benefit is clear: fewer project delays, smoother tech transfer, and less wasted time explaining details to outside agencies or collaborators.

    Besides researchers and pharma, our partnerships extend to contract manufacturers and specialty suppliers who integrate N-Acryloxysuccinimide into bigger, more complex systems. We consult on supply-chain strategy, recommend compatible reagents, and sometimes even redesign packaging for environments with extreme humidity or temperature swings.

    The Evolving Future for N-Acryloxysuccinimide

    From our vantage point, applications for N-Acryloxysuccinimide continue to expand. Nanotechnology researchers push boundaries by designing next-generation biosensors and composite materials, each with their own purity and stability requirements. Bioconjugation techniques keep growing more refined, with researchers focusing on single-atom precision for diagnostic imaging. Our role grows as a technical and collaborative partner, not just a bulk supplier. With emerging methods for site-selective modification in proteins and advanced materials, more synthetic challenges enter the market—each reaching farther into the limits of achievable purity and performance.

    Instead of resting on old formulations, we constantly update both product profiles and manufacturing technology. Automated reactors reduce batch variability and allow for real-time error correction. Data gathered are funneled straight to both process engineering and customer service, who anticipate demand spikes and address concerns before they reach crisis level.

    It has become routine for our plant to handle specialized blends and custom orders, sometimes at run times as short as a single day. Our operators, many with decades of experience, supply a living bridge between safe, reliable manufacture and the evolving world of cutting-edge research. The focus—always—remains on delivering not just product, but peace of mind to the scientists who rely on us each day.

    Direct Experience With Common User Questions

    Customers working in pharmaceutical process development often call to ask about batch-to-batch reproducibility, thermal stability, or best storage practices for N-Acryloxysuccinimide. These seemingly simple questions rest on years of plant floor iterations. For example, inorganic salt build-up in process water sources briefly caused inconsistent melting points several years ago, leading to an overhaul in our deionization strategy and installation of fresh filtration systems.

    Another frequent concern lies in cross-reactivity profiles. Polymer researchers looking to design functional hydrogels have tested system performance with our acryloxysuccinimide in both organic and aqueous conditions. We have developed clear guidelines for solvents, pH, and mixing temperatures, based on both our own R&D runs and published studies with our materials. The result is fewer failed experiments and more successful scale-up work, often communicated back to us through user publications or patent submissions.

    Conclusion of the Manufacturer's Viewpoint

    As the manufacturer, every lot of N-Acryloxysuccinimide that leaves our doorstep stands as the result of ongoing adjustment, learning, and adaptation to the needs of real world users. The product’s success owes as much to the diligence of plant operators and the feedback provided by hundreds of chemists and engineers as it does to chemical formula or theory. Our role extends beyond delivering white powder in a bag; it means standing behind every gram with practical answers, nimble adjustments, and the willingness to invest in better solutions as new challenges emerge across industries.

    Through direct experience, close industry partnerships, and a pragmatic approach to both innovation and risk, we continue to refine how we manufacture and support N-Acryloxysuccinimide. Supporting researchers tackling the next wave of challenges keeps our focus on practical excellence, scientific rigor, and the assurance that every batch continues to deliver on the most demanding scientific goals.